Ambu A/S

Equities

AMBU B

DK0060946788

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Copenhagen Other stock markets 11:20:00 2026-01-15 am EST			5-day change	1st Jan Change
90.15 ^DKK	-0.93%		+1.86%	+2.44%

Jan. 15	UBS Lowers Price Target for Ambu to 138 Danish Kroner (from 139), Reiterates Buy Rating	FW
Jan. 14	Ambu A/S Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-14-2026 08:15 AM

Ambu Launches New Share Buyback Program

Published on 12/10/2025 at 02:08 am EST

Finwire - Translated by Marketscreener - See original

Ambu A/S

-0.93%

BNP Paribas

+0.44%

Danish pharmaceutical company Ambu is initiating a new share buyback program, under which the company intends to repurchase its own shares for up to DKK 150 million between December 10, 2025, and no later than March 31, 2026.

BNP Paribas has been appointed as the main manager for the buyback operations.

Ambu holds a mandate to repurchase up to 10 percent of its share capital. Currently, the company owns a total of 1 percent of its capital.

Stocks mentioned in the article

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Price	Change	5d. change	Capi.
	AMBU A/S	90.15DKK	-0.93%	+1.86%	3.78B
	BNP PARIBAS	87.38EUR	+0.44%	+5.92%	112B

Latest news about Ambu A/S

Jan. 15	UBS Lowers Price Target for Ambu to 138 Danish Kroner (from 139), Reiterates Buy Rating	FW
Jan. 14	Ambu A/S Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-14-2026 08:15 AM
Dec. 18	Ambu A/S(CPSE:AMBU B) dropped from OMX Copenhagen 20 Index	CI
Dec. 10	Denmark's Ambu Launches DKK150 Million Share Buyback	MT
Dec. 10	Ambu Launches New Share Buyback Program	FW
Dec. 10	Ambu A/S (CPSE:AMBU B) commences an Equity Buyback Plan for 10% of its issued share capital, under the authorization approved on December 14, 2022.	CI
Dec. 03	Ambu A/S - Shareholder/Analyst Call
Dec. 01	Affärsvärlden Issues Buy Recommendation for Danish Company Ambu	FW
Nov. 14	UBS Lowers Price Target for Ambu to 139 Danish Kroner, Reiterates Buy	FW
Nov. 10	Ambu CFO Henrik Skak Bender Purchases Shares Worth Nearly 0.9 Million Danish Kroner	FW
Nov. 06	Danske Bank Lowers Ambu Price Target to 110 Danish Kroner, Maintains Buy Rating - BN	FW
Nov. 06	Nordea Lowers Ambu's Target Price to 115 Danish Kroner, Reiterates Buy Recommendation	FW
Nov. 06	SEB Lowers Target Price for Ambu to 152 Danish Kroner (165), Reiterates Buy	FW
Nov. 05	Ambu A/S announces Annual dividend, payable on December 08, 2025	CI
Nov. 05	European Markets Under Pressure as BMW Boosts Auto Stocks	RE
Nov. 05	Ambu A/S, Q4 2025 Earnings Call, Nov 05, 2025
Nov. 05	European shares close higher with earnings in spotlight; tech stocks waver	RE
Nov. 05	Ambu A/S Reports Earnings Results for the Full Year Ended September 30, 2025	CI
Nov. 05	Ambu A/S Reports Earnings Results for the Fourth Quarter and Full Year Ended September 30, 2025	CI
Nov. 05	Tech stocks pull European shares lower; earnings in focus	RE
Nov. 05	Ambu Reports Increased Revenue and Profit, Projects Double-Digit Growth for Coming Year	FW
Nov. 05	Ambu expects organic revenue growth of 10-13% in 2025/26	RE
Nov. 05	Ambu A/S Provides Financial Guidance for the Year 2025/26	CI
25-10-21	Novo Nordisk's top investor seizes board control in weight-loss drug battle	RE
25-10-21	Who's on Novo Nordisk's board after major shakeup?	RE

Chart Ambu A/S

Duration

Period

AMBU B: Dynamic Chart

Company Profile

Ambu A/S is specialized in the design, production and marketing of medical supplies. Net sales break down by family of products as follows: - emergency care and resuscitation devices (50.8%): mechanical ventilation devices (insufflators, laryngeal masks, facial masks and respiratory bags), secretion aspirators, immobilization devices, etc. In addition, the group sells dummies for first aid training centers; - single-use endoscopes (30.2%); - monitoring and diagnostic devices (19%): including electrodes used in the fields of cardiology, neurophysiology and first aid. At the end of September 2025, Ambu A/S had four production sites located in China, Malaysia, the United States and Mexico. Net sales are distributed geographically as follows: Denmark (1%), Europe (38.9%), the United States (49.3%), North America (1.2%) and other (9.6%).

Employees

5,384

Sector

Medical Equipment, Supplies & Distribution

Calendar

Feb. 03 - Q1 2026 Earnings Release

More about the company